• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白色念珠菌表型变异菌株对氟康唑、伊曲康唑和伏立康唑抗真菌活性的体外研究

In vitro investigation of antifungal activities of phenotypic variation Candida albicans strains against fluconazole, itraconazole and voriconazole.

作者信息

Cetinkaya Zafer, Kiraz Nuri

机构信息

Afyon Kocatepe University, Faculty of Medicine, Department of Microbiology, Turkey.

出版信息

Nihon Ishinkin Gakkai Zasshi. 2005;46(3):197-201. doi: 10.3314/jjmm.46.197.

DOI:10.3314/jjmm.46.197
PMID:16094296
Abstract

The aim of this study was to investigate the susceptibility of the different phenotypes of Candida albicans strains isolated from clinical specimens to three antifungal agents, fluconazole, itraconazole and voriconazole. Totally 215 specimens were collected from oropharyngeal, gastrointestinal and urogenital tracts of non-neutropenic patients who had received no previous prophylactic treatment. Each of the 215 C. albicans strains recovered was found to express one of the six phenotypes: smooth 73%, fuzzy 10.7%, irregular 2.3%, star 2.8%, ring 6% or stipple 5.1%. The mean MICs for the six phenotypes of C. albicans strains ranged between 0.25 microg/ml and 64 microg/ml for fluconazole, 0.03 microg/ml and 1 microg/ml for itraconazole and 0.03 microg/ml and 0.5 microg/ml for voriconazole. The mean minimum inhibitory concentration (MIC) of fluconazole was consistently higher for C. albicans strains expressing the stipple phenotype. The antifungal susceptibility of the phenotypic switching requires attention, especially in patients who are clinically unresponsive to fluconazole chemotherapy or in cases of serious C. albicans infections of immunocompromised hosts.

摘要

本研究的目的是调查从临床标本中分离出的白色念珠菌不同表型菌株对三种抗真菌药物氟康唑、伊曲康唑和伏立康唑的敏感性。总共从未接受过预防性治疗的非中性粒细胞减少患者的口咽、胃肠道和泌尿生殖道收集了215份标本。回收的215株白色念珠菌菌株中的每一株都被发现表达六种表型之一:光滑型73%、模糊型10.7%、不规则型2.3%、星型2.8%、环状型6%或点状型5.1%。白色念珠菌菌株六种表型对氟康唑的平均最低抑菌浓度(MIC)在0.25微克/毫升至64微克/毫升之间,对伊曲康唑为0.03微克/毫升至1微克/毫升,对伏立康唑为0.03微克/毫升至0.5微克/毫升。表达点状表型的白色念珠菌菌株对氟康唑的平均最低抑菌浓度一直较高。表型转换的抗真菌药敏性需要引起关注,尤其是在对氟康唑化疗无临床反应的患者或免疫功能低下宿主发生严重白色念珠菌感染的情况下。

相似文献

1
In vitro investigation of antifungal activities of phenotypic variation Candida albicans strains against fluconazole, itraconazole and voriconazole.白色念珠菌表型变异菌株对氟康唑、伊曲康唑和伏立康唑抗真菌活性的体外研究
Nihon Ishinkin Gakkai Zasshi. 2005;46(3):197-201. doi: 10.3314/jjmm.46.197.
2
Variable antifungal susceptibility of wild-type Candida albicans phenotypes from neutropenic hosts.中性粒细胞减少宿主来源的野生型白色念珠菌表型的抗真菌药敏性存在差异。
Eur J Clin Microbiol Infect Dis. 1996 Nov;15(11):854-60. doi: 10.1007/BF01691215.
3
Phenotypic variation and antifungal susceptibility patterns of Candida albicans strains isolated from neutropenic patients.从嗜中性白血球减少症患者中分离出的白色念珠菌菌株的表型变异和抗真菌药敏模式。
Mycoses. 2000;43(3-4):119-23. doi: 10.1046/j.1439-0507.2000.00569.x.
4
Comparative in vitro activity of voriconazole and itraconazole against fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida species from Spain.伏立康唑和伊曲康唑对来自西班牙的念珠菌属氟康唑敏感及氟康唑耐药临床分离株的体外活性比较
Eur J Clin Microbiol Infect Dis. 1999 Jun;18(6):432-5. doi: 10.1007/s100960050313.
5
Activity of voriconazole against Candida albicans and Candida krusei isolated since 1984.自1984年以来伏立康唑对白色念珠菌和克柔念珠菌的活性。
Int J Antimicrob Agents. 2000 Nov;16(3):205-9. doi: 10.1016/s0924-8579(00)00191-6.
6
In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates.伏立康唑、氟康唑、伊曲康唑和两性霉素B对非白色念珠菌酵母分离株的体外活性。
Rev Iberoam Micol. 2005 Mar;22(1):24-8. doi: 10.1016/s1130-1406(05)70002-4.
7
Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole.伏立康唑对氟康唑敏感和耐药念珠菌分离株的作用:与伊曲康唑和酮康唑相比的体外疗效
J Antimicrob Chemother. 1998 Aug;42(2):253-6. doi: 10.1093/jac/42.2.253.
8
Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.伏立康唑III期临床研究中,伏立康唑、伊曲康唑、氟康唑和两性霉素B对472例患者的1763株酵母菌的体外活性。
Int J Antimicrob Agents. 2008 Dec;32(6):511-4. doi: 10.1016/j.ijantimicag.2008.05.023. Epub 2008 Sep 13.
9
In vitro activities of fluconazole, itraconazole and voriconazole against otomycotic fungal pathogens.氟康唑、伊曲康唑和伏立康唑对耳真菌病原体的体外活性。
J Laryngol Otol. 2009 Sep;123(9):978-81. doi: 10.1017/S0022215109005489. Epub 2009 May 20.
10
In vitro susceptibility of Candida spp. to fluconazole, itraconazole and voriconazole and the correlation between triazoles susceptibility: Results from a five-year study.念珠菌属对氟康唑、伊曲康唑和伏立康唑的体外敏感性及三唑类药物敏感性的相关性:一项为期五年的研究结果。
J Mycol Med. 2018 Jun;28(2):310-313. doi: 10.1016/j.mycmed.2018.03.005.